Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    0.00 (0.00%)
Bid:
807.00
Ask:
809.00
Spread: 2.00 (0.248%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

14 May 2025 07:00

RNS Number : 5368I
Savills PLC
14 May 2025
 

14 May 2025

SAVILLS PLC

 

("Savills" or "the Company")

 

Trading update

 

Ahead of its Annual General Meeting (AGM) to be held at 12 noon today at Savills, 33 Margaret Street, London W1G 0JD, Savills plc, the international real estate advisor issues the following trading update:

 

Savills has traded broadly in line with our expectations in the first quarter and for the year to date, and comfortably ahead of the comparable period last year. 

 

Highlights:

 

· Our global capital transaction revenue improved (+7% in Q1), particularly in EMEA and, with some exceptions, values are largely recalibrated in most prime markets. There is renewed investor interest in prime core office stock throughout Europe.

· Leasing revenues grew over 20% in Q1 as markets have continued to be more active across most sectors.

· Most prime residential markets have remained resilient through Q1 with the UK performing better than last year in advance of the increase in Stamp Duty.

· Savills less transactional businesses (Property Management, Investment Management and Consultancy) have performed as expected, with a particularly strong performance in Consultancy.

· The uncertainty created by recent macro-economic and geopolitical events has resulted in a short term slow-down in global transaction activity, which we expect to recover as sentiment becomes more certain.

· The Group's underlying pipeline of potential transactions is significantly improved compared with the same time last year.

 

Our less transactional businesses continue to provide a solid platform for the Group with a resilient earnings stream. Meanwhile on the transactional side, there remains significant investor interest in the secure income characteristics of real estate, and in most major cities the office market is seeing much greater investor demand.

 

Outlook

 

We continue to develop our business through selective recruitment and acquisitions, supported by a strong balance sheet.

 

We expect that the impact of tariffs on the execution of transactions in Q2 means that Savills H1 performance may be largely similar to last year, however we anticipate continued improvement in market conditions through the second half of the year.

 

The Group's Half Year Results for the six months to 30 June will be announced on 14 August 2025.

 

Mark Ridley, Chief Executive, commented:

 

"We have had a good start to the year with performance comfortably ahead of the prior year, reflecting progressive recovery in most markets. The current macro-level uncertainty is clearly having a near term impact on transactional activity, as investors and corporates digest the potential effects of recent events. However, I am confident that the underlying trajectories for our transactional businesses are substantially improved year-on-year. I am delighted with the performance of our teams worldwide in helping clients navigate these circumstances and in seeking longer term business development initiatives, which our strong balance sheet enables us to pursue."

 

 

 

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Teneo 020 7353 4200

Elizabeth Snow

Jo Blackshaw

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSAEDIVLIE
Date   Source Headline
24th Nov 20223:25 pmRNSDirector/PDMR Shareholding
14th Nov 20229:29 amRNSDirector/PDMR Shareholding
11th Oct 20224:21 pmRNSDirector/PDMR Shareholding
10th Oct 20224:36 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:24 pmRNSDirector/PDMR Shareholding
1st Sep 202210:07 amRNSTotal Voting Rights
31st Aug 202210:00 amRNSDirector/PDMR Shareholding
16th Aug 20223:33 pmRNSBlock listing Interim Review
16th Aug 202211:12 amRNSDirector/PDMR Shareholding
11th Aug 20224:12 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSHalf-year Report
12th Jul 20223:34 pmRNSDirector/PDMR Shareholding
1st Jul 20223:56 pmRNSDirector/PDMR Shareholding
1st Jul 202210:00 amRNSTotal Voting Rights
20th Jun 20224:33 pmRNSHolding(s) in Company
17th Jun 20227:29 amRNSHolding(s) in Company
15th Jun 202212:00 pmRNSHolding(s) in Company
10th Jun 20223:46 pmRNSHolding(s) in Company
1st Jun 20222:22 pmRNSHolding(s) in Company
1st Jun 202210:00 amRNSTotal Voting Rights
31st May 20222:53 pmRNSHolding(s) in Company
27th May 202210:00 amRNSHolding(s) in Company
26th May 20223:56 pmRNSDirector/PDMR Shareholding
17th May 20225:17 pmRNSHolding(s) in Company
17th May 20225:12 pmRNSHolding(s) in Company
11th May 20225:44 pmRNSDirector/PDMR Shareholding
11th May 20222:22 pmRNSResult of AGM
11th May 20229:56 amRNSAGM Statement
3rd May 20227:00 amRNSTotal Voting Rights
27th Apr 20224:13 pmRNSDirectors Remuneration Report - Clarification
21st Apr 20224:57 pmRNSDirector/PDMR Shareholding
21st Apr 20224:44 pmRNSHolding(s) in Company
12th Apr 20222:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:28 pmRNSAnnual Report and AGM Notice
1st Apr 202210:00 amRNSTotal Voting Rights
14th Mar 202210:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSFinal Results
3rd Mar 202211:00 amRNSTotal Voting Rights
15th Feb 202211:00 amRNSBlock listing Interim Review
14th Feb 202212:00 pmRNSDirector/PDMR Shareholding
1st Feb 202210:27 amRNSTotal Voting Rights
21st Jan 202210:00 amRNSBlock listing Interim Review
12th Jan 20227:00 amRNSYear End Trading Update
11th Jan 20223:04 pmRNSDirector/PDMR Shareholding
4th Jan 202211:19 amRNSTotal Voting Rights
31st Dec 202110:06 amRNSSavills IM & Samsung Life Investment Alliance
13th Dec 202112:38 pmRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSTotal Voting Rights
25th Nov 202112:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.